Finance News – Trpv3 Inhibitor

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Shares Ceo Tariffs Investors Stock Stock Market Crypto Assets Cryptocurrency Ethereum Price Markets Xrp Bse Etf Stablecoin Eth Investment Blockchain Ipo Index Solana Earnings Sec Trade Inflation Revenue Interest Rates Sensex Token Coinbase Wall Street Treasury Nasdaq Federal Reserve Nse Bse Sensex China Traders Nifty Sp 500 Profit Gold Investor Tesla Company Economy Meta Platforms Sbi Card Mining Project Builderai Cetus Dex Tariff Impacts Norfolk Southern Point Of Purchase Regulatory Report Us Crypto Regulation

Filter by:

Trpv3 Inhibitor ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →